Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Prevalence and profile of inherited metabolic disorders in Libya: single center experience

Breadcrumb

  • Home
  • Prevalence and profile of inherited metabolic disorders in Libya: single center experience

Maryem Elbashier Ismail 1, *, Tawfeg Ben-Omran 2, Ayman Balla Mustafa 3 and Amro Mohamed Abdel-Azeem 4

1 Department of pediatrics, Faculty of Medicine, Misurata University, Libya.
2 Department of Pediatrics, Hamad Medical Corporation, Qatar.
3 Department of Therapeutic Nutrition, Faculty of Health Sciences, Misurata University, Misurata, Libya.
4 Department of Community, Environmental and Occupational Medicine, Faculty of Medicine Zagazig University, Zagazig, Egypt.
 

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2022, 10(03), 060–064.
Article DOI: 10.30574/wjbphs.2022.10.3.0085
DOI url: https://doi.org/10.30574/wjbphs.2022.10.3.0085

Received on 07 May 2022; revised on 19 June 2022; accepted on 21 June 2022
 

Background: Inherited Metabolic Disorders (IMDs) are collectively common, particularly in a highly consanguineous population. Early diagnosis and prompt treatment are crucial to prevent permanent damage to the central nervous system as well as other devastating irreparable damage and even death. This study was conducted to determine the prevalence of IMDs in children seen at the Pediatric Department, Faculty of Medicine, Misurata University, Libya.
Methods: In this cross-sectional study, medical records of all patients with IMDs over 6 years’ experience were studied. Related information to age, gender, consanguinity, family history, disorder type, diagnostic criteria and disease outcomes were extracted and analyzed. RESULTS: 57 patients were included in this study; 39 patients were male (68.4%) and 18 patients were females (31.6%) [M: F= 2.17:1] and the mean age at diagnosis was 1.9 years. Consanguinity was reported in 47 patients (82.5%), with family history being found in 71.9% of patients. 16 patients have mucopolysaccharidosis (28.1%), 11 patients have Glycogen storage diseases (19.3%),4 Nieman pick disease (7%), while the rest constitute the small molecular weight disease.
Conclusion: IMDs are an up growing field of medicine, initial baseline diagnostic tools could take place in any specialized center and newborn screening should be established in Libya because of the high prevalence of IMDs. The lysosomal storage diseases are particularly common; however, many were still undiagnosed.

 Inborn Errors; Inherited; Metabolic Diseases; Prevalence

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2022-0085.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Maryem Elbashier Ismail, Tawfeg Ben-Omran, Ayman Balla Mustafa and Amro Mohamed Abdel-Azeem. Prevalence and profile of inherited metabolic disorders in Libya: single center experience. World Journal of Biology Pharmacy and Health Sciences, 2022, 10(03), 060–064. Article DOI: https://doi.org/10.30574/wjbphs.2022.10.3.0085

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution